According to reports, AstraZeneca has already negotiated a merger with Bristol-Myers Squibb. People familiar with the matter said that these discussions took place in recent months and are still likely to come to an end. The report did not detail the exact structure of any potential deal. As of last Friday, the market capitalization of AstraZeneca and Bristol-Myers Squibb was £19.6 billion and $133 billion, respectively.

According to reports, AstraZeneca has already negotiated a merger with Bristol-Myers Squibb. People familiar with the matter said that these discussions took place in recent months and are still likely to come to an end. The report did not detail the exact structure of any potential deal. As of last Friday, the market capitalization of AstraZeneca and Bristol-Myers Squibb was £19.6 billion and $133 billion, respectively.